Date: Wednesday, October 19, 2016
Time: 11am EDT (NA) / 4pm BST (UK) / 5pm CEST (EU-Central)
Duration: 60 minutes
Enzo Medico, MD, PhD, Associate Professor, University of Torino, School of Medicine, Candiolo Cancer Institute
In this webinar, we will examine how using integrative genomic techniques in cancer research has the potential to transform the future of colorectal cancer therapy.
Oncogenomics research conducted by featured speaker, Dr Enzo Medico, have described stromal gene expression signatures which go beyond providing assessment of stromal cell fraction in the tumor. This additionally provides information on stromal composition and functional state which can be used to highlight clinically relevant correlates.
Join this live webinar that includes a Q&A session with
Dr Medico on the topic of RNA-seq in Colorectal Cancer.
|ABOUT THE SPEAKER|
Enzo Medico, associate professor at the University of Torino, graduated in Medicine from the same University in 1989. He received his Ph.D. from the University “La Sapienza” of Rome in 1994. Since 2004 he is head of the Laboratory of Oncogenomics at the Candiolo Cancer Institute, Italy. His research has been focusing on cancer genomics since 1998, when he developed a “gene trapping” approach for genome-wide exploration of transcriptional regulation at the Fred Hutchinson Cancer Research Center. He subsequently worked with George Church at Harvard Medical School, exploiting microarray analysis to define gene expression programs associated to invasive growth of normal and neoplastic cells. During the last ten years he has been working at translational genomics of colorectal cancer, combining bioinformatics, genomics data generation and experimental functional analysis in cell lines and patient-derived tumor xenografts.